Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Bertagnolli raises paylines, creates Clinical Trials Innovation Unit, and announces National Cancer Plan
NCI

Bertagnolli raises paylines, creates Clinical Trials Innovation Unit, and announces National Cancer Plan

February 10, 2023
Vol.49 No.06
By Matthew Bin Han Ong
Biden places cancer in top spot on Unity Agenda; announces new Moonshot programs
White House

Biden places cancer in top spot on Unity Agenda; announces new Moonshot programs

February 10, 2023
Vol.49 No.06
By Matthew Bin Han Ong
Jedd Wolchok: Weill Cornell’s path to NCI designation runs through Brooklyn and Queens
Conversation with The Cancer Letter

Jedd Wolchok: Weill Cornell’s path to NCI designation runs through Brooklyn and Queens

January 13, 2023
Vol.49 No.02
By Paul Goldberg
In Brief

Kevin Cullen to retire as director of UMGCCC

January 13, 2023
Vol.49 No.02
NIH, NCI budgets up by more than 5% in FY23; FDA gets more robust accelerated approval authority
Capitol Hill

NIH, NCI budgets up by more than 5% in FY23; FDA gets more robust accelerated approval authority

January 06, 2023
Vol.49 No.01
By Matthew Bin Han Ong
NCI oral history: J. Palmer Saunders on being tasked to investigate NCI’s Chemotherapy Program
FreeIn the Archives

NCI oral history: J. Palmer Saunders on being tasked to investigate NCI’s Chemotherapy Program

January 06, 2023
Vol.49 No.01
NCI’s Cancer Prevention-Interception Targeted Agent Discovery (CAP-IT) Program, a milestone in cancer prevention research
FreeGuest Editorial

NCI’s Cancer Prevention-Interception Targeted Agent Discovery (CAP-IT) Program, a milestone in cancer prevention research

December 21, 2022
Vol.48 No.46
By Margie Clapper
Top 25 stories of 2022
EditorialFree

Top 25 stories of 2022

December 21, 2022
Vol.48 No.46
By Alexandria Carolan and Katie Goldberg
NCI BSA approves eight new, reissue concepts at BSA/NCAB joint meeting

NCI BSA approves eight new, reissue concepts at BSA/NCAB joint meeting

December 16, 2022
Vol.48 No.45
By Jacquelyn Cobb
The National Cancer Act 20 years later: impact as seen by its architects in 1991
In the Archives

The National Cancer Act 20 years later: impact as seen by its architects in 1991

December 16, 2022
Vol.48 No.45

Posts navigation

Previous1…262728…38Next

Trending Stories

  • Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
  • FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
    “Patients are owed another review.”
  • Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
  • CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show
  • CBER Director Vinay Prasad dared to “say no to drugs”
  • J. Craig Venter’s work was foundational to cancer advancement of the past 25 years

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account